Physician profile
Daniel Anton Beck
NPI 1780688465
$3,877.80
in general payments reported to CMS, 2019-2025
32 companies · $1,138 in 2025
The $1,138 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $482 · 2023: $1,078 · 2024: $973 · 2025: $1,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,189.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $601.66 | 2023-2025 | Relistor |
| Edwards Lifesciences Corporation | $460.89 | 2021-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Inspiris Resilia Aortic Valve |
| Getinge USA Sales, LLC | $455.08 | 2022-2023 | Vasoview Hemopro 2 |
| Medtronic, INC. | $346.79 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $343.26 | 2023-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $274.55 | 2024-2025 | Eterna, Proclaim |
| Atricure, INC. | $216.54 | 2022-2023 | |
| Valinor Pharma, LLC | $174.65 | 2024-2025 | Movantik |
| Abbvie INC. | $153.37 | 2024-2025 | |
| Globus Medical, INC. | $144.55 | 2025 | Creo, Acp, Senza |
| Avanir Pharmaceuticals, INC. | $106.61 | 2021 | |
| Protega Pharmaceutials INC | $79.82 | 2025 | Roxybond |
| Spinal Simplicity, LLC | $73.03 | 2025 | Ha Minuteman G3-R |
| Depuy Synthes Sales INC. | $38.58 | 2023 | Monovisc, Orthovisc |
| Ethicon US, LLC | $36.08 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $34.85 | 2024 | Prolate, Nalocet |
| Si-Bone, INC. | $33.61 | 2024 | |
| Lilly USA, LLC | $28.91 | 2023 | Reyvow, Emgality |
| Saluda Medical Americas, INC. | $28.84 | 2025 | Evoke |
| Ferring Pharmaceuticals INC. | $26.53 | 2023 | Euflexxa |
| Integra Lifesciences Corporation | $25.55 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Stryker Corporation | $23.80 | 2021 | |
| Spr Therapeutics, INC | $22.41 | 2025 | Sprint Pns System |
| Bioventus LLC | $22.36 | 2023 | Gelsyn-3 |
| Lundbeck LLC | $17.95 | 2023 | Vyepti |
| Nevro Corp. | $16.91 | 2023 | Senza |
| Nalu Medical, INC. | $16.52 | 2023 | Nalu Neurostimulation System |
| Pfizer INC. | $16.12 | 2023 | |
| Foundation Fusion Solutions, LLC | $15.77 | 2024 | |
| Orthofix Medical, INC. | $14.72 | 2025 | Physio-Stim |
| Idorsia Pharmaceuticals US INC | $14.01 | 2024 | Quviviq |
| Painteq LLC | $13.48 | 2024 | Painteq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.